Cohort studycited by the Tayebat archiveabstract only checked A-ABX-04 standard review

Infant antibiotics and asthma (UK)

Antibiotic exposure in the first two years of life and development of asthma and other allergic diseases by 7.5 yr: a dose-dependent relationship.

Overview

Hoskin-Parr L et al.. Pediatr Allergy Immunol 2013 · PMID 24299467 · DOI 10.1111/pai.12153

More antibiotic courses were linked to more asthma at age 7.

Does the study support the specific claim? Partly · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Link to asthma.

How was the study done?

Cohort.

How many people, animals or samples were studied?

4952.

What was actually found?

Dose-response.

How large was the observed effect?

OR 2.82 (4+).

What do the results mean in everyday life?

May be confounded.

What are the study's limitations?

Reverse causation.

What does it say about Elawady's specific claim?

Association.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Causation.

Scientific in-depth review

1. Full reference

Authors
Hoskin-Parr L, Teyhan A, Blocker A, Henderson AJ
Journal
Pediatr Allergy Immunol
Year
2013
Identifier
PMID 24299467 DOI 10.1111/pai.12153 · PMC3995010
Verification
verified – PubMed E-utilities efetch, 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract/record (grants: Medical Research Council, Wellcome Trust)

2. Research question

Antibiotics 0-2 years and asthma/allergy at 7.5 years

3. Study design and population

Study design
Cohort study – ALSPAC birth cohort, logistic regression
Population

Children

Country

UK

Period

ALSPAC

Sample size

4952

Inclusion and exclusion criteria

ALSPAC

4. Methods and endpoints

Exposure / intervention

Number of courses

Comparator

None

Endpoints

Asthma, eczema, hay fever, atopy

Statistical methods

Multivariable logistic

5. Actual results

Results

Any OR 1.75 (1.40-2.17); >=4 courses OR 2.82 (2.19-3.63); not with atopy.

Absolute risks

not reported

Authors' conclusion

Robust, dose-dependent association; not mediated through atopy.

6. Strengths

  • Dose-response

7. Weaknesses

  • Maternal report
  • Protopathic bias likely

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
high
Rationale

Respiratory symptoms of early asthma may prompt antibiotics.

9. Assessment of the statistical interpretation

Association.

10. Relevance to the specific claim

C-ABX-06.

11. Independent contrary findings

I-ABX-03.

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Association likely confounded.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biashigh
Precision of resultsmoderate
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks

Use by the Tayebat archive

Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.

What the archive says about the study

Bibliography only.

A. What was actually studied?

Antibiotics and asthma.

B. What did the authors find?

Dose-dependent association.

C. What conclusions do the authors themselves draw?

Robust association.

D. What does the archive derive from it?

Supports 'linked to asthma'.

E. Is this derivation scientifically justified?

Justified as link; causality doubtful (I-ABX-03).

Adequacy of the interpretation (by the archive)
not applicable